Impala Asset Management’s Pfizer PFE Stock Holding History

Impala Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-166,507	Closed	-$5.8M	–	63
2020 Q3	$5.8M	Buy	+166,507	New	+$5.84M	0.58%	36

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Impala Asset Management's PFE Position: Q4 2020 in Review

Impala Asset Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 166,507 shares — an estimated $5.8M sold.

Impala Asset Management first reported a position in PFE in Q3 2020 and held it in 1 quarter. The position peaked at $5.8M in Q3 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Impala Asset Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
Impala Asset Management sold 166,507 Pfizer shares in Q4 2020, an estimated $5.8M.
Impala Asset Management first reported a position in Pfizer in Q3 2020 and held it in 1 quarter.
Impala Asset Management's Pfizer position peaked at $5.8M in Q3 2020.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Impala Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.